Cargando…
DNA-binding domain fusions enhance the targeting range and precision of Cas9
The CRISPR-Cas9 system is commonly employed in biomedical research; however, the precision of Cas9 is sub-optimal for gene therapy applications that involve editing a large population of cells. Variations on the standard Cas9 system have yielded improvements in the precision of targeted DNA cleavage...
Autores principales: | Bolukbasi, Mehmet Fatih, Gupta, Ankit, Oikemus, Sarah, Derr, Alan G., Garber, Manuel, Brodsky, Michael H., Zhu, Lihua Julie, Wolfe, Scot A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679368/ https://www.ncbi.nlm.nih.gov/pubmed/26480473 http://dx.doi.org/10.1038/nmeth.3624 |
Ejemplares similares
-
Orthogonal Cas9–Cas9 chimeras provide a versatile platform for genome editing
por: Bolukbasi, Mehmet Fatih, et al.
Publicado: (2018) -
Publisher Correction: Orthogonal Cas9-Cas9 chimeras provide a versatile platform for genome editing
por: Bolukbasi, Mehmet Fatih, et al.
Publicado: (2018) -
GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases
por: Zhu, Lihua Julie, et al.
Publicado: (2017) -
Enhanced Cas12a editing in mammalian cells and zebrafish
por: Liu, Pengpeng, et al.
Publicado: (2019) -
NmeCas9 is an intrinsically high-fidelity genome-editing platform
por: Amrani, Nadia, et al.
Publicado: (2018)